FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula I and pharmaceutically acceptable salts thereof, which can be used for treating aldosterone-mediated diseases.
EFFECT: invention also relates to pharmaceutical compositions which contain compound of formula I.
11 cl, 52 tbl, 55 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
| HETEROARYL[4,3-c]PYRIMIDINE-5-AMINE DERIVATIVE, ITS PREPARATION METHOD AND ITS MEDICAL APPLICATIONS | 2018 |
|
RU2764655C2 |
| SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
| CYTOSKELETALLY ACTIVE RHO-KINASE INHIBITING COMPOUNDS, COMPOSITIONS AND USE THEREOF | 2007 |
|
RU2470928C2 |
| AMIDE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREFOR AND MEDICINAL APPLICATION THEREOF | 2015 |
|
RU2681537C2 |
| 5-SUBSTITUTED INDAZOLE AS KINASE INHIBITORS | 2008 |
|
RU2487873C2 |
| METHOD FOR TREATING INFLAMMATION OR INFLAMMATION-INDUCED DISEASE IN DOGS | 1996 |
|
RU2253456C2 |
| AZETIDINYL DIAMIDES AS MONOACYLGLICEROL LIPASE INHIBITORS | 2010 |
|
RU2569298C2 |
| 2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
